What does Idylla® mean for cancer patients?
Idylla® provides accurate, actionable results with direct impact on treatment choice.
• IdyllaTM solid biopsy assays focus on clinically relevant mutations
• Clear reporting
• According to clinical guidelines of ASCO, ESMO, NCCN and IASLC
Therapeutic area | Genes | Clinically Relevant Mutations |
---|---|---|
Melanoma | BRAF | 7 mutations in codon 600 |
Colorectal Cancer | KRAS NRAS BRAF |
21 mutations in codons
12, 13, 59, 61, 117, 146 18 mutations in codons 12, 13, 59, 61, 117, 146 5 mutations in codon 600 |
Lung cancer | EGFR | 51 mutations in exons 18, 19, 20, 21 |
Why wait weeks instead of days?
From sample to treatment initiation in 1-2 days.
Molecular testing
Traditional Way | Idylla® Way |
---|---|
In or outside your hospital
|
In your hospital
|
1-4 days turnaround time of test
cumbersome workflow/manual steps |
< 2.5 hours turnaround time of test
fully automated |
grouping of patient samples
1/week or bi-weekly |
individual patient sample
on demand |
from sample treatment to initiation
on average 18 days |
from sample treatment to initiation
in 1-2 days |